How much funding has Marrow Access Technologies raised?

Marrow Access Technologies has raised $241K in total funding, most recently a Seed round.

Who are Marrow Access Technologies's investors?

Marrow Access Technologies's investors include Plug and Play.

When was Marrow Access Technologies founded?

Marrow Access Technologies was founded in 2017.

Where is Marrow Access Technologies headquartered?

Marrow Access Technologies is headquartered in Warsaw, Indiana, United States.

What industry is Marrow Access Technologies in?

Marrow Access Technologies operates in Medtech.

How many employees does Marrow Access Technologies have?

Marrow Access Technologies has 1-10 employees.

Marrow Access Technologies

Optimizing bone marrow stimulation for natural healing

Warsaw, United States · Founded 2017 · $241K raised

Medtech

Headquarters: Warsaw, Indiana
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: marrowaccess.com
Total Funding: $241K
Last Round: $241K SeedMar 2024
Rounds: 1

About

Marrow Access Technologies delivers next-generation solutions for bone marrow stimulation in orthopedics and sports medicine. The company's flagship product, the SmartShot® Marrow Access Device, uses a 1mm microneedle to provide controlled, consistent access to the marrow space without drilling or fracturing subchondral bone—preserving bone architecture and supporting natural cartilage healing. SmartShot is purpose-built for sports medicine and orthopedic procedures including ankle, knee, hip, wrist, and elbow cartilage repair, and is used by surgeons as a modern alternative to legacy microfracture techniques.

Summary

Marrow Access Technologies is a Medtech company based in Warsaw, United States, founded in 2017. It has raised $241K in total across 1 round, most recently a $241K Seed round in Mar 2024. Investors include Plug and Play.